Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: a randomised, open-label study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 150, Issue 2, 2010, Pages 203-206

  Aydin, Yavuz ^a   Atis, Alev ^b   Kaleli, Semih ^a   Uludaǧ, Seyfettin ^a   Goker, Nimet ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Breast; Mastalgia; Pain; Premenstrual syndrome; Prolactin

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; PROLACTIN;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTALGIA; MENSTRUAL CYCLE; NAUSEA; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT RESPONSE; VISUAL ANALOG SCALE; VOMITING;

EID: 77952107282     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2010.02.024     Document Type: Article

References (27)

1. Davies E.L., Gateley C.A., Miers M., and Mansel R.E. The long-term course of mastalgia. J R Soc Med 91 (1998) 462-464
2. Preece P.E., Mansel R.E., Bolton P.M., Hughes L.M., Baum M., and Gravelle I.H. Clinical syndromes of mastalgia. Lancet 2 (1976) 670-673
3. Millet A.V., and Dirbas F.M. Clinical manegement of breast pain: a review. Obstet Gynecol Surv 176 (2002) 998-1005
4. Mansel R.E., and Dogliotti L. Europian multicentre trial of bromocriptine in cyclical mastalgia. Lancet 35 (1990) 190-193
5. Messinis I.E., and Lolis D. Treatment of premenstrual mastalgia with tamoxifen. Acta Obstet Gynecol Scand 67 (1988) 307-309
6. Gong C., Song E., Jia W., et al. A double blind randomised controlled trial of tromifen therapy for mastalgia. Arch Surg 141 (2006) 43-47
7. Sharma A.K., Mishra S.K., Salila M., Ramesh V., and Bal S. Cyclical mastalgia-is it a manifestation of abberation in lipid metabolism?. Indian J Physiol Pharmacol 38 (1994) 267-271
8. Alder D.N., and Brown M.W. Prevalence and impact of cyclic mastalgia in United States clinic-based sample. Am J Obstet Gynecol 177 (1997) 126-132
9. Genolet P.M., Deloleye J.F., and de Drandi P. Diagnosis and treatment of mastodynia. Ann Med Interne 13 (1996) 31-33
10. Kaleli S., Aydin Y., Erel C.T., and Colgar U. Symtomatic treatment of premenstruel mastalgia in premenopausal women with lisuride maleate: a double-blind placebo controlled randomised study. Fertil Steril 75 (2001) 718-723
11. O'Brein P.M., and Abukhalil I.E. Randomised controlled trialof the manegement of premenstruel syndrome and premenstruel mastalgia using luteal phase-onlydanazole. Am J Obstet Gynecol (1999) 18018-18023
12. Mansel R.E., Goyal A., Preece P., Leinster S., Maddox P.R., Gateley C., et al. European randomised, multicentre study of goserelin (zoladex) in the manegement of mastalgia. Am J Obstet Gynecol 191 (2004) 1942-1949
13. Smith R.L., Pruthi S., and Fitzpatric L.A. Evaluation and manegement of breast pain. Mayo Clin Proc 79 (2004) 353-372
14. Konstostolis E., Stefanidis K., NavrozoglouI, and Lolis D. Comparison of tamoxifen with donazol for treatment of cyclic mastalgia. Gynecol Endocrinol 11 (1997) 393-397
15. Oksa S., Luukkaala T., and Maenpaa J. Tromifenfor premenstruel mastalgia: a randomised, placebo controlled crossover study. BJOG 113 (2006) 713-718
16. Marttunen M.B., Cacciatore B., Hietanen P., Pyhonen S., Tiitinen A., Wahlstrom T., et al. Prospective study on gynecological effects of two antiestrogens tamoxifen and tromifenein postmenopausal women. Br J Cancer 84 (2001) 897-902
17. Tomas E., Kauppila A., Blanco G., Apaja-Sarkkinen M., and Laatikainen T. Comparison between the effects of tamoxifen and tromifene on the uterus in postmenopausal breast cancer patients. Gynecol Oncol 59 (1995) 261-266
18. Onnis A., Nardilli G., Mozzenega Blamaina V., Onnis G.L., Maggino T., et al. Progestinic treatment of mastodinia. New suggestion for the follow-up. Eur J Gyneacol Oncol 1 (1984) 407-409
19. Kumar S., Mansel R.E., and Scanlon M.F. Altered responses of prolactin, luteinizing hormone and follicle stumulating hormone secretion to thyrotrphin releasing hormone/gonodotrophine releasing hormone stimulation in cyclical mastalgia. Br J Surg 71 (1984) 870-873
20. Colao A., di Sarno A., Pivonello R., di Somma C., and Lombardi G. Dopamine receptor agonists for treating prolactinomas. Expert Opin Investig Drugs 11 (2002) 782-800
21. Barlier A., and Jaquet P. Quinagolide-a valuable treatment option for hyperprolactinemia. Eur J Endocrinol 154 (2006) 187-195
22. Gillam M.P., Fideleff H., Boquete H.R., and Molitch M.E. Prolactin excess: treatment and toxicity. Pediatr Endocrinol Rev 2 (2004) 108-114
23. Srivastava A., Mansel R.E., Arvind N., Prasad K., Dhar A., and Chabra A. Evidence-based management of Mastalgia: a meta-analysis of randomised trials. Breast 16 October (5) (2007) 503-512 (Epub 2007 May 16)
24. Mansel R.E., and Hughes L.E. Breast pain and nodularity. In: Hughes L.E., Mansel R.E., and Webster D.J.T. (Eds). Benign disorders and diseases of the breast. 2nd ed. (2000), WB Saunders, Philadelphia, PA 95-122
25. Zanetti R., Antonini A., Gatto G., Gentile R., Tesei S., and Pezzoli G. Valvular heart disease and use of dopamine agonists for Parkinson's disease. N Engl J Med 356 (2007) 39-46
26. Simonis G., Fuhrmann J.T., and Strasser R.H. Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists. Mov Disord 22 (2007) 1936-1942
27. Hoffman C., Penner U., Dorow R., et al. Lisuride, a dopamine agonist with 5-HT2B receptor agonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis. Clin Neuropharmacol 29 (2006) 80-86